
M28 CAPITAL MANAGEMENT LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | IVVD | 9.25M | $10.17M |
![]() | WVE | 5.66M | $41.46M |
![]() | GUTS | 1.86M | $2.95M |
![]() | PRQR | 1.02M | $2.17M |
![]() | CRIS | 521K | $864.96K |
![]() | RCKT | 386K | $1.26M |
![]() | SLN | 185K | $960.67K |
![]() | TGTX | 162K | $5.84M |
![]() | ARWR | 67K | $2.32M |

Invivyd, Inc.
IVVD
Shares Held
9.25M
Value
$10.17M

Wave Life Sciences Ltd.
WVE
Shares Held
5.66M
Value
$41.46M

Fractyl Health, Inc. Common Stock
GUTS
Shares Held
1.86M
Value
$2.95M

ProQR Therapeutics N.V.
PRQR
Shares Held
1.02M
Value
$2.17M

Curis, Inc.
CRIS
Shares Held
521K
Value
$864.96K

Rocket Pharmaceuticals, Inc.
RCKT
Shares Held
386K
Value
$1.26M

Silence Therapeutics plc
SLN
Shares Held
185K
Value
$960.67K

TG Therapeutics, Inc.
TGTX
Shares Held
162K
Value
$5.84M

Arrowhead Pharmaceuticals, Inc.
ARWR
Shares Held
67K
Value
$2.32M
